 | • レポートコード：D005-14946 • 出版社/出版日：GlobalInfoResearch / 2020年5月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、無菌注射薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。無菌注射薬の種類別市場規模（サイトカイン、インスリン、ペプチドホルモン、ワクチン、免疫グロブリン、血液因子、ペプチド抗生物質、その他）、用途別市場規模（がん、糖尿病、心血管疾患、筋骨格系、CNS、感染症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Baxter International、GILEAD SCIENCES、AstraZeneca、Sanofi、Pfizer、GlaxoSmithKline、Novartis、Merck、Johnson & Johnson Services ・地域別グローバル市場分析 2015年-2020年 ・無菌注射薬の北米市場（アメリカ、カナダ、メキシコ） ・無菌注射薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・無菌注射薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・無菌注射薬の南米市場（ブラジル、アルゼンチン） ・無菌注射薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：サイトカイン、インスリン、ペプチドホルモン、ワクチン、免疫グロブリン、血液因子、ペプチド抗生物質、その他 ・用途別分析：がん、糖尿病、心血管疾患、筋骨格系、CNS、感染症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Sterile Injectable Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 4258.5 million by 2025, from USD 3506.7 million in 2019.
The Sterile Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sterile Injectable Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sterile Injectable Drugs market has been segmented into
Cytokines
Insulin
Peptide hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide antibiotics
Others
By Application, Sterile Injectable Drugs has been segmented into:
Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sterile Injectable Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Sterile Injectable Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sterile Injectable Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Sterile Injectable Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Sterile Injectable Drugs Market Share Analysis
Sterile Injectable Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sterile Injectable Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sterile Injectable Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Sterile Injectable Drugs are:
Baxter International
GILEAD SCIENCES
AstraZeneca
Sanofi
Pfizer
GlaxoSmithKline
Novartis
Merck
Johnson & Johnson Services
Among other players domestic and global, Sterile Injectable Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sterile Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sterile Injectable Drugs, with price, sales, revenue and global market share of Sterile Injectable Drugs in 2018 and 2019.
Chapter 3, the Sterile Injectable Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sterile Injectable Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Sterile Injectable Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Sterile Injectable Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Sterile Injectable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sterile Injectable Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cytokines
1.2.3 Insulin
1.2.4 Peptide hormones
1.2.5 Vaccines
1.2.6 Immunoglobulins
1.2.7 Blood Factors
1.2.8 Peptide antibiotics
1.2.9 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sterile Injectable Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Musculoskeletal
1.3.6 CNS
1.3.7 Infections
1.3.8 Others
1.4 Overview of Global Sterile Injectable Drugs Market
1.4.1 Global Sterile Injectable Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Baxter International
2.1.1 Baxter International Details
2.1.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Baxter International SWOT Analysis
2.1.4 Baxter International Product and Services
2.1.5 Baxter International Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GILEAD SCIENCES
2.2.1 GILEAD SCIENCES Details
2.2.2 GILEAD SCIENCES Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GILEAD SCIENCES SWOT Analysis
2.2.4 GILEAD SCIENCES Product and Services
2.2.5 GILEAD SCIENCES Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis SWOT Analysis
2.7.4 Novartis Product and Services
2.7.5 Novartis Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson Services
2.9.1 Johnson & Johnson Services Details
2.9.2 Johnson & Johnson Services Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson Services SWOT Analysis
2.9.4 Johnson & Johnson Services Product and Services
2.9.5 Johnson & Johnson Services Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Sterile Injectable Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Sterile Injectable Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sterile Injectable Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Sterile Injectable Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Sterile Injectable Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Sterile Injectable Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Sterile Injectable Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
4.5 South America Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Sterile Injectable Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Sterile Injectable Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Sterile Injectable Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Sterile Injectable Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Sterile Injectable Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Sterile Injectable Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
6.3 UK Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
6.4 France Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sterile Injectable Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Sterile Injectable Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Sterile Injectable Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
7.5 India Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Sterile Injectable Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Sterile Injectable Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Sterile Injectable Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sterile Injectable Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Sterile Injectable Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Sterile Injectable Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Sterile Injectable Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Sterile Injectable Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Sterile Injectable Drugs Price by Type (2015-2020)
11 Global Sterile Injectable Drugs Market Segment by Application
11.1 Global Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
11.2 Global Sterile Injectable Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Sterile Injectable Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Sterile Injectable Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Sterile Injectable Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Sterile Injectable Drugs Market Forecast (2021-2025)
12.2.2 Europe Sterile Injectable Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Sterile Injectable Drugs Market Forecast (2021-2025)
12.2.4 South America Sterile Injectable Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Sterile Injectable Drugs Market Forecast (2021-2025)
12.3 Sterile Injectable Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Sterile Injectable Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Sterile Injectable Drugs Market Share Forecast by Type (2021-2025)
12.4 Sterile Injectable Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Sterile Injectable Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Sterile Injectable Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Sterile Injectable Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sterile Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sterile Injectable Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Baxter International Basic Information, Manufacturing Base and Competitors
Table 8. Baxter International Sterile Injectable Drugs Major Business
Table 9. Baxter International Sterile Injectable Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Baxter International SWOT Analysis
Table 11. Baxter International Sterile Injectable Drugs Product and Services
Table 12. Baxter International Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GILEAD SCIENCES Basic Information, Manufacturing Base and Competitors
Table 14. GILEAD SCIENCES Sterile Injectable Drugs Major Business
Table 15. GILEAD SCIENCES Sterile Injectable Drugs Total Revenue (USD Million) (2018-2019)
Table 16. GILEAD SCIENCES SWOT Analysis
Table 17. GILEAD SCIENCES Sterile Injectable Drugs Product and Services
Table 18. GILEAD SCIENCES Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Sterile Injectable Drugs Major Business
Table 21. AstraZeneca Sterile Injectable Drugs Total Revenue (USD Million) (2018-2019)
Table 22. AstraZeneca SWOT Analysis
Table 23. AstraZeneca Sterile Injectable Drugs Product and Services
Table 24. AstraZeneca Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi Sterile Injectable Drugs Major Business
Table 27. Sanofi Sterile Injectable Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Sanofi SWOT Analysis
Table 29. Sanofi Sterile Injectable Drugs Product and Services
Table 30. Sanofi Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Sterile Injectable Drugs Major Business
Table 33. Pfizer Sterile Injectable Drugs Total Revenue (USD Million) (2018-2019)
Table 34. Pfizer SWOT Analysis
Table 35. Pfizer Sterile Injectable Drugs Product and Services
Table 36. Pfizer Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 38. GlaxoSmithKline Sterile Injectable Drugs Major Business
Table 39. GlaxoSmithKline Sterile Injectable Drugs Total Revenue (USD Million) (2018-2019)
Table 40. GlaxoSmithKline SWOT Analysis
Table 41. GlaxoSmithKline Sterile Injectable Drugs Product and Services
Table 42. GlaxoSmithKline Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Sterile Injectable Drugs Major Business
Table 45. Novartis Sterile Injectable Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Novartis SWOT Analysis
Table 47. Novartis Sterile Injectable Drugs Product and Services
Table 48. Novartis Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck Basic Information, Manufacturing Base and Competitors
Table 50. Merck Sterile Injectable Drugs Major Business
Table 51. Merck Sterile Injectable Drugs Total Revenue (USD Million) (2018-2019)
Table 52. Merck SWOT Analysis
Table 53. Merck Sterile Injectable Drugs Product and Services
Table 54. Merck Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table 56. Johnson & Johnson Services Sterile Injectable Drugs Major Business
Table 57. Johnson & Johnson Services Sterile Injectable Drugs Total Revenue (USD Million) (2018-2019)
Table 58. Johnson & Johnson Services SWOT Analysis
Table 59. Johnson & Johnson Services Sterile Injectable Drugs Product and Services
Table 60. Johnson & Johnson Services Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Sterile Injectable Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Sterile Injectable Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Sterile Injectable Drugs Sales by Regions (2015-2020) (K Units)
Table 64. Global Sterile Injectable Drugs Sales Market Share by Regions (2015-2020)
Table 65. Global Sterile Injectable Drugs Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Sterile Injectable Drugs Sales by Countries (2015-2020) (K Units)
Table 67. North America Sterile Injectable Drugs Sales Market Share by Countries (2015-2020)
Table 68. North America Sterile Injectable Drugs Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Sterile Injectable Drugs Revenue Market Share by Countries (2015-2020)
Table 70. Europe Sterile Injectable Drugs Sales by Countries (2015-2020) (K Units)
Table 71. Europe Sterile Injectable Drugs Sales Market Share by Countries (2015-2020)
Table 72. Europe Sterile Injectable Drugs Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Sterile Injectable Drugs Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Sterile Injectable Drugs Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Sterile Injectable Drugs Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Sterile Injectable Drugs Sales by Countries (2015-2020) (K Units)
Table 77. South America Sterile Injectable Drugs Sales Market Share by Countries (2015-2020)
Table 78. South America Sterile Injectable Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Sterile Injectable Drugs Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Sterile Injectable Drugs Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Sterile Injectable Drugs Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Sterile Injectable Drugs Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Sterile Injectable Drugs Revenue Market Share by Countries (2015-2020)
Table 84. Global Sterile Injectable Drugs Sales by Type (2015-2020) (K Units)
Table 85. Global Sterile Injectable Drugs Sales Share by Type (2015-2020)
Table 86. Global Sterile Injectable Drugs Revenue by Type (2015-2020) (USD Million)
Table 87. Global Sterile Injectable Drugs Revenue Share by Type (2015-2020)
Table 88. Global Sterile Injectable Drugs Sales by Application (2015-2020) (K Units)
Table 89. Global Sterile Injectable Drugs Sales Share by Application (2015-2020)
Table 90. Global Sterile Injectable Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Sterile Injectable Drugs Market Share Forecast by Regions (2021-2025)
Table 92. Global Sterile Injectable Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Sterile Injectable Drugs Market Share Forecast by Type (2021-2025)
Table 94. Global Sterile Injectable Drugs Sales Forecast by Application (2021-2025)
Table 95. Global Sterile Injectable Drugs Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Sterile Injectable Drugs Picture
Figure 2. Global Sales Market Share of Sterile Injectable Drugs by Type in 2019
Figure 3. Cytokines Picture
Figure 4. Insulin Picture
Figure 5. Peptide hormones Picture
Figure 6. Vaccines Picture
Figure 7. Immunoglobulins Picture
Figure 8. Blood Factors Picture
Figure 9. Peptide antibiotics Picture
Figure 10. Others Picture
Figure 11. Sterile Injectable Drugs Sales Market Share by Application in 2018
Figure 12. Cancer Picture
Figure 13. Diabetes Picture
Figure 14. Cardiovascular Diseases Picture
Figure 15. Musculoskeletal Picture
Figure 16. CNS Picture
Figure 17. Infections Picture
Figure 18. Others Picture
Figure 19. Global Sterile Injectable Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 20. United States Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Canada Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Mexico Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Germany Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. France Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. UK Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Russia Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Italy Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. China Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Japan Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Korea Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. India Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Southeast Asia Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Australia Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 34. Brazil Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Egypt Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Saudi Arabia Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 37. South Africa Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 38. Turkey Sterile Injectable Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 39. Global Sterile Injectable Drugs Sales Market Share by Manufacturer in 2019
Figure 40. Global Sterile Injectable Drugs Revenue Market Share by Manufacturer in 2019
Figure 41. Top 3 Sterile Injectable Drugs Manufacturer (Revenue) Market Share in 2019
Figure 42. Top 6 Sterile Injectable Drugs Manufacturer (Revenue) Market Share in 2019
Figure 43. Key Manufacturer Market Share Trend
Figure 44. Global Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 45. Global Sterile Injectable Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. Global Sterile Injectable Drugs Revenue Market Share by Regions (2015-2020)
Figure 47. Global Sterile Injectable Drugs Revenue Market Share by Regions in 2018
Figure 48. North America Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
Figure 49. Europe Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
Figure 50. Asia-Pacific Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
Figure 51. South America Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
Figure 52. Middle East & Africa Sterile Injectable Drugs Sales and Growth Rate (2015-2020)
Figure 53. North America Sterile Injectable Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. North America Sterile Injectable Drugs Sales Market Share by Countries (2015-2020)
Figure 55. North America Sterile Injectable Drugs Sales Market Share by Countries in 2018
Figure 56. North America Sterile Injectable Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 57. North America Sterile Injectable Drugs Revenue Market Share by Countries in 2018
Figure 58. United States Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Canada Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Mexico Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Europe Sterile Injectable Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Europe Sterile Injectable Drugs Revenue Market Share by Countries (2015-2020)
Figure 63. Europe Sterile Injectable Drugs Revenue Market Share by Countries in 2019
Figure 64. Germany Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. UK Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. France Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Russia Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Italy Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Asia-Pacific Sterile Injectable Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. Asia-Pacific Sterile Injectable Drugs Sales Market Share by Regions 2019
Figure 71. Asia-Pacific Sterile Injectable Drugs Revenue Market Share by Regions 2019
Figure 72. China Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Japan Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Korea Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. India Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Southeast Asia Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. South America Sterile Injectable Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. South America Sterile Injectable Drugs Sales Market Share by Countries in 2019
Figure 79. South America Sterile Injectable Drugs Revenue Market Share by Countries in 2019
Figure 80. Brazil Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Argentina Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Middle East and Africa Sterile Injectable Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 83. Middle East and Africa Sterile Injectable Drugs Sales Market Share by Countries in 2019
Figure 84. Middle East and Africa Sterile Injectable Drugs Revenue Market Share by Countries (2015-2020)
Figure 85. Middle East and Africa Sterile Injectable Drugs Revenue Market Share by Countries in 2019
Figure 86. Saudi Arabia Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 87. Egypt Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 88. Turkey Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 89. South Africa Sterile Injectable Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 90. Global Sterile Injectable Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 91. Global Sterile Injectable Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 92. North America Sales Sterile Injectable Drugs Market Forecast (2021-2025) (K Units)
Figure 93. Europe Sales Sterile Injectable Drugs Market Forecast (2021-2025) (K Units)
Figure 94. Asia-Pacific Sales Sterile Injectable Drugs Market Forecast (2021-2025) (K Units)
Figure 95. South America Sales Sterile Injectable Drugs Market Forecast (2021-2025) (K Units)
Figure 96. Middle East & Africa Sales Sterile Injectable Drugs Market Forecast (2021-2025) (K Units)
Figure 97. Sales Channel: Direct Channel vs Indirect Channel
一般無菌注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Generic Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 63660 million by 2025, from USD 51320 million in 2019. The Generic Ste…- ジェネリック腫瘍滅菌注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Generic Oncology Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 12600 million by 2025, from USD 9912.3 million in 2019. The G…
- ペプチド及び抗凝固薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Peptide and Anticoagulant Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 652.8 million by 2025, from USD 477.3 million in 2019. The Peptid…
- 抗凝血薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Blood-thinning Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Blood-thinning Drugs mar…
- 滅菌注射剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sterile Injectables market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 377.3 million by 2025, from USD 323 million in 2019. The Sterile Injectables …